← Insider trading tracker

Every insider trade Manuel Alba has disclosed

Director · Astera Labs, Inc. (ALAB)

Key points

  • Manuel Alba has disclosed 8 Form 4 transactions between Sep 2, 2025 and Sep 1, 2026: 8 sales worth $214M and no open-market buys.
  • Of the 8 sales, 8 were under a pre-scheduled 10b5-1 plan, leaving 0 discretionary sales worth $0.
  • The largest single transaction is a sell of 136,974 shares of ALAB worth $60.5M, filed Jul 6, 2026.
  • Insider selling is not on its own a bearish signal — plans, taxes and diversification all drive sales. This page is a record of disclosed trades, not investment advice.
  • The most recent filing on record was made Sep 3, 2026. Insiders file within two business days of a trade.

This is the public record of open-market stock transactions Manuel Alba has reported to the SEC on Form 4 as Director of Astera Labs, Inc. (ALAB). Every figure below is the reported share count multiplied by the reported price, so the dollar amounts are exact disclosed values rather than estimates. It is a record of what has been filed, not a portfolio or a recommendation, and insider selling in particular is routine and rarely a signal on its own.

Buying vs selling at a glance

MeasureOpen-market buysSales
Transactions08
Total disclosed value$0$214M
Discretionary (own call)00 ($0)

Most of Manuel Alba's sales were pre-scheduled or tax-related rather than discretionary, which further weakens any read of them as a market call.

Every disclosed transaction

All 8 disclosed transactions, newest filing first.

StockActionSharesPriceValueTradedFiled
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan183,000$280.13$51.3MSep 1, 2026Sep 3, 2026
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan8,491$458.38$3.9MJul 1, 2026Jul 6, 2026
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan37,535$447.39$16.8MJul 1, 2026Jul 6, 2026
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan136,974$442.01$60.5MJul 1, 2026Jul 6, 2026
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan183,000$107.61$19.7MApr 1, 2026Apr 3, 2026
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan33,000$166.18$5.5MDec 1, 2025Dec 3, 2025
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan150,000$166.18$24.9MDec 1, 2025Dec 3, 2025
ALAB Astera Labs, Inc.▼ Sell 10b5-1 plan183,000$173.27$31.7MSep 2, 2025Sep 4, 2025

Questions about this record

How many shares has Manuel Alba bought and sold?

Manuel Alba has disclosed 8 Form 4 transactions in the record we track, from Sep 2, 2025 to Sep 1, 2026: 8 sales worth $214,304,295 and no open-market purchases. Each figure is the reported share count multiplied by the reported price, so these are exact disclosed amounts, not estimates.

Is Manuel Alba selling a bearish signal?

Not on its own. Insiders sell for many reasons that have nothing to do with a view on the stock — diversification, taxes, estate planning, or a pre-scheduled plan set up months earlier. Of the 8 sales on this record, 8 were made under a Rule 10b5-1 plan and 0 were automatic tax withholding on vesting shares, leaving 0 that were the insider's own discretionary decision (worth $0). Buying is the cleaner signal, because there is only one reason to buy. This page is a record, not a recommendation.

What is Manuel Alba's role?

Manuel Alba files as Director of Astera Labs, Inc. (ALAB). That role is taken from the Form 4 filings themselves. A Form 4 is filed with the SEC within two business days of an insider buying or selling their own company's stock.

What was Manuel Alba's largest single transaction?

The largest single transaction on record is a sell of 136,974 shares of ALAB at $442.01, worth $60,543,455, filed Jul 6, 2026.

How current is this record?

The most recent Form 4 here was filed Sep 3, 2026. Insiders have two business days to file after a trade, so this is close to real time, but it is a record of what has been disclosed, not a statement of what Manuel Alba currently holds. Amounts are open-market and plan transactions reported on Form 4; grants and option exercises are not counted as buys.

Source: Form 4 filings submitted to the SEC, the same public documents behind our insider trading tracker. Figures are open-market and plan transactions only; grants and option exercises are not counted as buys. A disclosure is not evidence of a market view, and none of this is investment advice. See the full ALAB stock page for price, filings and coverage.